NR1I2 and colonic neoplasm: Our results indicated that PXR activation led to increased proliferation and MDR in colon cancer cells; however, the concurrent administration of FLCWK with 5‐FU effectively reversed the MDR linked to 5‐FU, offering significant implications for future clinical applications.